Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10089)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2013 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Provenzani A, Santeusanio A, Mathis E, Notarbartolo M, Labbozzetta M, Poma P, Provenzani A, Polidori C, Vizzini G, Polidori P, D’Alessandro N. Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients. World J Gastroenterol 2013; 19(48): 9156-9173 [PMID: 24409044 DOI: 10.3748/wjg.v19.i48.9156] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i48/9156.htm |
| Number | Citing Articles |
| 1 |
Elias Khajeh, Georgios Polychronidis, Ali Ramouz, Parnian Alamdari, Anastasia Lemekhova, Melisa Saracevic, Sadeq Ali-Hasan-Al-Saegh, Omid Ghamarnejad, Ali Majlesara, Sepehr Abbasi Dezfouli, Arash Nickkholgh, Karl Heinz Weiss, Christian Rupp, Arianeb Mehrabi, Markus Mieth. Evaluation of the impact of Tacrolimus-based immunosuppression on Heidelberg liver transplant cohort (HDTACRO). Medicine 2020; 99(39): e22180 doi: 10.1097/MD.0000000000022180
|
| 2 |
Konstantin Feinberg, Kiana Tajdaran, Kaveh Mirmoeini, Simeon C. Daeschler, Mario A. Henriquez, Katelyn E. Stevens, Chilando M. Mulenga, Arif Hussain, Pedram Hamrah, Asim Ali, Tessa Gordon, Gregory H. Borschel. The Role of Sensory Innervation in Homeostatic and Injury-Induced Corneal Epithelial Renewal. International Journal of Molecular Sciences 2023; 24(16): 12615 doi: 10.3390/ijms241612615
|
| 3 |
Pei Wen Ong, Terence Kee, Quan Yao Ho. Impact of tacrolimus versus cyclosporine on one-year renal transplant outcomes: A single-centre retrospective cohort study. Proceedings of Singapore Healthcare 2020; 29(4): 217 doi: 10.1177/2010105820957370
|
| 4 |
Pauline Lancia, Beate Aurich, Phuong Ha, Anne Maisin, Véronique Baudouin, Evelyne Jacqz-Aigrain. Adverse Events under Tacrolimus and Cyclosporine in the First 3 Years Post-Renal Transplantation in Children. Clinical Drug Investigation 2018; 38(2): 157 doi: 10.1007/s40261-017-0594-0
|
| 5 |
John R. Lee, Thangamani Muthukumar, Darshana Dadhania, Ying Taur, Robert R. Jenq, Nora C. Toussaint, Lilan Ling, Eric Pamer, Manikkam Suthanthiran, Stanislaw Stepkowski. Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation. PLOS ONE 2015; 10(3): e0122399 doi: 10.1371/journal.pone.0122399
|
| 6 |
Naomi Hauser, Tanmay Sahai, Rocco Richards, Todd Roberts. High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana. Case Reports in Transplantation 2016; 2016: 1 doi: 10.1155/2016/4028492
|
| 7 |
Lu Chen, Xiaoqing Lu, Guijun Tan, Liqin Zhu, Yihe Liu, Mengxue Li. Impact of body composition on pharmacokinetics of tacrolimus in liver transplantation recipients. Xenobiotica 2020; 50(2): 196 doi: 10.1080/00498254.2019.1607918
|
| 8 |
James M. Stevenson, April Schultz, Amanda Massmann, Joel Van Heukelom, Casey Overby Taylor. Clinical Decision Support for Pharmacogenomic Precision Medicine. 2022; : 175 doi: 10.1016/B978-0-12-824453-1.00005-1
|
| 9 |
Xiaoqing Zhang, Jiandong Xu, Junwei Fan, Tao Zhang, Yuping Li, Boxiong Xie, Wei Zhang, Shengtao Lin, Ling Ye, Yuan Liu, Gening Jiang. Influence of IL-18 and IL-10 Polymorphisms on Tacrolimus Elimination in Chinese Lung Transplant Patients. Disease Markers 2017; 2017: 1 doi: 10.1155/2017/7834035
|
| 10 |
Neven Vavic, Aleksandar Tomic, Predrag Aleksic, Katarina Obrencevic, Milorad Radojevic, Ljiljana Ignjatovic, Predrag Maric, Mirko Jovanovic, Nemanja Rancic, Djoko Maksic. Graft and patient survival after renal transplantation in the period from 1996-2017 in Military Medical Academy, Belgrade, Serbia. Vojnosanitetski pregled 2022; 79(3): 243 doi: 10.2298/VSP190313091V
|
| 11 |
Valentina Urzì Brancati, Carmelo Scarpignato, Letteria Minutoli, Giovanni Pallio. Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients. Biomedicines 2022; 10(8): 1798 doi: 10.3390/biomedicines10081798
|
| 12 |
Fabiana D.V. Genvigir, Patricia C. Salgado, Claudia R. Felipe, Elena Y.F. Luo, Camila Alves, Alvaro Cerda, Helio Tedesco-Silva, Jose O. Medina-Pestana, Nagilla Oliveira, Alice C. Rodrigues, Sonia Q. Doi, Mario H. Hirata, Rosario D.C. Hirata. Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients. Pharmacogenetics and Genomics 2016; 26(10): 462 doi: 10.1097/FPC.0000000000000237
|
| 13 |
Alessio Provenzani, Alfred L’Altrelli, Piera Polidori. Contemporary Lung Transplantation. Organ and Tissue Transplantation 2022; : 1 doi: 10.1007/978-3-319-20788-9_27-1
|
| 14 |
Tsvetelin Lukanov, Milena Ivanova, Petya Yankova, Bushra Al Hadra, Anastasiya Mihaylova, Marianka Genova, Dobrin Svinarov, Elisaveta Naumova. Impact of CYP3A7, CYP2D6 and ABCC2/ABCC3 polymorphisms on tacrolimus steady state concentrations in Bulgarian kidney transplant recipients. Biotechnology & Biotechnological Equipment 2022; 36(1): 362 doi: 10.1080/13102818.2022.2081517
|
| 15 |
Vasileios Fragoulakis, Margarita-Ioanna Koufaki, Candace Joefield-Roka, Gere Sunder-Plassmann, Christina Mitropoulou. Cost-utility analysis of pharmacogenomics-guided tacrolimus treatment in Austrian kidney transplant recipients participating in the U-PGx PREPARE study. The Pharmacogenomics Journal 2024; 24(2) doi: 10.1038/s41397-024-00330-5
|
| 16 |
Zhu Zhang, Xiaobei Lu, Leipeng Dong, Jiwei Ma, Xiaoguang Fan. Clinical observation on the effect of Wuzhi soft capsule on FK506 concentration in membranous nephropathy patients. Medicine 2019; 98(48): e18150 doi: 10.1097/MD.0000000000018150
|
| 17 |
Wei Wang, Khawar Ali Shahzad, Miaochen Li, Aifeng Zhang, Lei Zhang, Tao Xu, Xin Wan, Chuanlai Shen. An Antigen-Presenting and Apoptosis-Inducing Polymer Microparticle Prolongs Alloskin Graft Survival by Selectively and Markedly Depleting Alloreactive CD8+ T Cells. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00657
|
| 18 |
Simeon C. Daeschler, Kaveh Mirmoeini, Tessa Gordon, Katelyn Chan, Jennifer Zhang, Asim Ali, Konstantin Feinberg, Gregory H. Borschel. Sustained Release of Tacrolimus From a Topical Drug Delivery System Promotes Corneal Reinnervation. Translational Vision Science & Technology 2022; 11(8): 20 doi: 10.1167/tvst.11.8.20
|
| 19 |
Maja Nowicka, Monika Górska, Zuzanna Nowicka, Krzysztof Edyko, Piotr Edyko, Sebastian Wiślicki, Anna Zawiasa-Bryszewska, Janusz Strzelczyk, Józef Matych, Ilona Kurnatowska. Tacrolimus: Influence of the Posttransplant Concentration/Dose Ratio on Kidney Graft Function in a Two-Year Follow-Up. Kidney and Blood Pressure Research 2019; 44(5): 1075 doi: 10.1159/000502290
|
| 20 |
Marwa Helal, Manar Obada, Wael Abd Elrazek, Manal Safan, Tarek Abd El-Hakim, Hala El-Said. Effect of ABCB1 (3435C>T) and CYP3A5 (6986A>G) genes polymorphism on tacrolimus concentrations and dosage requirements in liver transplant patients. Egyptian Journal of Medical Human Genetics 2017; 18(3): 261 doi: 10.1016/j.ejmhg.2016.10.005
|
| 21 |
Tomislav Kelava, Petra Turcic, Antonio Markotic, Ana Ostojic, Dino Sisl, Anna Mrzljak. Importance of genetic polymorphisms in liver transplantation outcomes. World Journal of Gastroenterology 2020; 26(12): 1273-1285 doi: 10.3748/wjg.v26.i12.1273
|
| 22 |
Máté Déri, Zsófia Szakál-Tóth, Ferenc Fekete, Katalin Mangó, Evelyn Incze, Annamária Minus, Béla Merkely, Balázs Sax, Katalin Monostory. CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-00942-y
|
| 23 |
Pier Luigi Calvo, Loredana Serpe, Andrea Brunati, Antonello Nonnato, Daniela Bongioanni, Dominic Dell' Olio, Michele Pinon, Carlo Ferretti, Francesco Tandoi, Giulia Carbonaro, Mauro Salizzoni, Antonio Amoroso, Renato Romagnoli, Roberto Canaparo. Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantation. British Journal of Clinical Pharmacology 2017; 83(6): 1252 doi: 10.1111/bcp.13219
|
| 24 |
Franc Andreu, Helena Colom, Laure Elens, Teun van Gelder, Ronald H. N. van Schaik, Dennis A. Hesselink, Oriol Bestard, Joan Torras, Josep M. Cruzado, Josep M. Grinyó, Nuria Lloberas. A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach. Clinical Pharmacokinetics 2017; 56(8): 963 doi: 10.1007/s40262-016-0491-3
|
| 25 |
Hanaa Wanas, Mai Hamed Kamel, Emad Adel William, Tarek Fayad, Mohamed Essmat Abdelfattah, Hossein Mostafa Elbadawy, Emily Samir Mikhael. The impact of CYP3A4 and CYP3A5 genetic variations on tacrolimus treatment of living‐donor Egyptian kidney transplanted patients. Journal of Clinical Laboratory Analysis 2023; 37(19-20) doi: 10.1002/jcla.24969
|
| 26 |
Dirk Theile, Nicolas Hohmann, Dominik Kiemel, Giuseppe Gattuso, Davide Barreca, Gerd Mikus, Walter Emil Haefeli, Vedat Schwenger, Johanna Weiss. Clementine juice has the potential for drug interactions – In vitro comparison with grapefruit and mandarin juice. European Journal of Pharmaceutical Sciences 2017; 97: 247 doi: 10.1016/j.ejps.2016.11.021
|
| 27 |
Alessio Provenzani, Manuela Labbozzetta, Monica Notarbartolo, Paola Poma, Piera Polidori, Giovanni Vizzini, Natale D’Alessandro. Rash and multiorgan dysfunction following lamotrigine: could genetic be involved?. International Journal of Clinical Pharmacy 2015; 37(5): 682 doi: 10.1007/s11096-015-0158-4
|
| 28 |
Raja Al-Bahou, Julia Bruner, Helen Moore, Ali Zarrinpar. Quantitative methods for optimizing patient outcomes in liver transplantation. Liver Transplantation 2024; 30(3): 311 doi: 10.1097/LVT.0000000000000325
|
| 29 |
Josep M Grinyó, Stefano Petruzzelli. Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations. Expert Review of Clinical Immunology 2014; 10(12): 1567 doi: 10.1586/1744666X.2014.983903
|
| 30 |
L.-S. Liu, J. Li, X.-T. Chen, H.-X. Zhang, Q. Fu, H.-Y. Wang, Y.-Y. Xiong, S. Liu, X.-M. Liu, J.-L. Li, M. Huang, C.-X. Wang. Comparison of tacrolimus and cyclosporin A in CYP3A5 expressing Chinesede novokidney transplant recipients: a 2-year prospective study. International Journal of Clinical Practice 2015; 69: 43 doi: 10.1111/ijcp.12666
|
| 31 |
Bérenger Largeau, Chantal Barin-Le Guellec, Hélène Longuet, Philippe Lesne, Antoine Bouvarel, Laura Préteseille, Pierre Marquet, Jean-Michel Halimi, Matthias Büchler, Philippe Gatault, Johan Noble. Comparison of Tacrolimus Starting Doses Based on CYP3A5 Phenotype or Genotype in Kidney Transplant Recipients. Progress in Transplantation 2019; 29(4): 300 doi: 10.1177/1526924819873905
|
| 32 |
Benjamin Renaud-Picard, Angela Koutsokera, Michael Cabanero, Tereza Martinu. Acute Rejection in the Modern Lung Transplant Era. Seminars in Respiratory and Critical Care Medicine 2021; 42(03): 411 doi: 10.1055/s-0041-1729542
|
| 33 |
Luis Sendra Gisbert, Antonio Miguel Matas, Luis Sabater Ortí, María José Herrero, Laura Sabater Olivas, Eva María Montalvá Orón, Matteo Frasson, Rafael Abargues López, Rafael López‐Andújar, Eduardo García‐Granero Ximénez, Salvador Francisco Aliño Pellicer. Efficacy of hydrodynamic interleukin 10 gene transfer in human liver segments with interest in transplantation. Liver Transplantation 2017; 23(1): 50 doi: 10.1002/lt.24667
|
| 34 |
Jesus Ruiz, María Herrero, Virginia Bosó, Juan Megías, David Hervás, Jose Poveda, Juan Escrivá, Amparo Pastor, Amparo Solé, Salvador Aliño. Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation. International Journal of Molecular Sciences 2015; 16(9): 20168 doi: 10.3390/ijms160920168
|
| 35 |
Annop Phupradit, Somratai Vadcharavivad, Atiporn Ingsathit, Surasak Kantachuvesiri, Nutthada Areepium, Supasil Sra-ium, Titinun Auamnoy, Chonlaphat Sukasem, Vasant Sumethkul, Chagriya Kitiyakara. Impact of POR and CYP3A5 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in the Early Post-operative Period Following Kidney Transplantation. Therapeutic Drug Monitoring 2018; 40(5): 549 doi: 10.1097/FTD.0000000000000542
|
| 36 |
Sivadasan Kanangat, Ina Skaljic. Microbiome analysis, the immune response and transplantation in the era of next generation sequencing. Human Immunology 2021; 82(11): 883 doi: 10.1016/j.humimm.2021.07.009
|
| 37 |
Paige Verona, Jocelyn Edwards, Kassidy Hubert, Federica Avorio, Vincenzina Lo Re, Roberta Di Stefano, Anna Carollo, Heather Johnson, Alessio Provenzani. Tacrolimus-Induced Neurotoxicity After Transplant: A Literature Review. Drug Safety 2024; 47(5): 419 doi: 10.1007/s40264-024-01398-5
|
| 38 |
James M. Neuberger, Wolf O. Bechstein, Dirk R.J. Kuypers, Patrizia Burra, Franco Citterio, Sabina De Geest, Christophe Duvoux, Alan G. Jardine, Nassim Kamar, Bernhard K. Krämer, Herold J. Metselaar, Frederik Nevens, Jacques Pirenne, Manuel L. Rodríguez-Perálvarez, Didier Samuel, Stefan Schneeberger, Daniel Serón, Pavel Trunečka, Giuseppe Tisone, Teun van Gelder. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients. Transplantation 2017; 101(4S): S1 doi: 10.1097/TP.0000000000001651
|
| 39 |
Kannan Sridharan, Shamik Shah, Anfal Jassim, Mona Hammad, Johaina Ebrahim Al Gadhban, Ola Al Segai. Evaluation of Pharmacogenetics of Drug-Metabolizing Enzymes and Drug Efflux Transporter in Renal Transplants Receiving Immunosuppressants. Journal of Personalized Medicine 2022; 12(5): 823 doi: 10.3390/jpm12050823
|
| 40 |
Zhaolin Chen, Xi Cheng, Liwen Zhang, Liqin Tang, Yan Fang, Hongxiao Chen, Lei Zhang, Aizong Shen. The impact of IL-10 and CYP3A5 gene polymorphisms on dose-adjusted trough blood tacrolimus concentrations in early post-renal transplant recipients. Pharmacological Reports 2021; 73(5): 1418 doi: 10.1007/s43440-021-00288-2
|
| 41 |
Ana Sánchez Fructuoso, Juan Carlos Ruiz, Antonio Franco, Fritz Diekmann, Dolores Redondo, Jesús Calviño, Nuria Serra, María José Aladrén, Secundino Cigarrán, Ana Manonelles, Ana Ramos, Gonzalo Gómez, José Manuel González Posada, Amado Andrés, Isabel Beneyto, Andrés López Muñiz, Manel Perelló, Ricardo Lauzurica. Effectiveness and safety of the conversion to MeltDose® extended‐release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study. Clinical Transplantation 2020; 34(1) doi: 10.1111/ctr.13767
|
| 42 |
Michele Pinon, Amedeo De Nicolò, Antonio Pizzol, Miriam Antonucci, Antonio D’Avolio, Loredana Serpe, Dominic Dell’Olio, Silvia Catalano, Francesco Tandoi, Renato Romagnoli, Roberto Canaparo, Pier Luigi Calvo. Early impact of donor CYP3A5 genotype and Graft-to-Recipient Weight Ratio on tacrolimus pharmacokinetics in pediatric liver transplant patients. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-020-79574-7
|
| 43 |
Narayan Prasad, Akhilesh Jaiswal, Manas Ranjan Behera, Vikas Agarwal, Ravi Kushwaha, Dharmendra Bhadauria, Anupama Kaul, Amit Gupta. Melding Pharmacogenomic Effect of MDR1 and CYP3A5 Gene Polymorphism on Tacrolimus Dosing in Renal Transplant Recipients in Northern India. Kidney International Reports 2020; 5(1): 28 doi: 10.1016/j.ekir.2019.09.013
|
| 44 |
Nóra Csikány, Ádám Kiss, Máté Déri, Ferenc Fekete, Annamária Minus, Katalin Tóth, Manna Temesvári, Enikő Sárváry, László Bihari, Zsuzsa Gerlei, László Kóbori, Katalin Monostory. Clinical significance of personalized tacrolimus dosing by adjusting to donor CYP3A‐status in liver transplant recipients. British Journal of Clinical Pharmacology 2021; 87(4): 1790 doi: 10.1111/bcp.14566
|
| 45 |
Livija Šimičević, Iva Canjuga, Lada Zibar, Ana Borić‐Bilušić, Lana Ganoci, Nada Božina. Rapid clearance of tacrolimus blood concentration triggered by variant pharmacogenes. Journal of Clinical Pharmacy and Therapeutics 2022; 47(9): 1461 doi: 10.1111/jcpt.13650
|
| 46 |
|
| 47 |
Karly P. Garnock-Jones. Tacrolimus Prolonged Release (Envarsus®): A Review of Its Use in Kidney and Liver Transplant Recipients. Drugs 2015; 75(3): 309 doi: 10.1007/s40265-015-0349-2
|
| 48 |
L. Yeo, A. D. Ormerod. Oral tacrolimus: a treatment option for recalcitrant erosive lichen planus. Clinical and Experimental Dermatology 2016; 41(6): 684 doi: 10.1111/ced.12858
|
| 49 |
Stefanny M. Figueroa, Jean-Philippe Bertocchio, Toshifumi Nakamura, Soumaya El-Moghrabi, Frédéric Jaisser, Cristián A. Amador. The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice. Pharmaceutics 2023; 15(5): 1373 doi: 10.3390/pharmaceutics15051373
|
| 50 |
Jing Zhu, Tejendra Patel, Jordan A. Miller, Chad D. Torrice, Mehak Aggarwal, Margaret R. Sketch, Maurice D. Alexander, Paul M. Armistead, James M. Coghill, Tatjana Grgic, Katarzyna J. Jamieson, Jonathan R. Ptachcinski, Marcie L. Riches, Jonathan S. Serody, John L. Schmitz, J. Ryan Shaw, Thomas C. Shea, Oscar Suzuki, Benjamin G. Vincent, William A. Wood, Kamakshi V. Rao, Tim Wiltshire, Eric T. Weimer, Daniel J. Crona. Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients. International Journal of Molecular Sciences 2020; 21(3): 858 doi: 10.3390/ijms21030858
|
| 51 |
Giovanni Piotti, Elena Cremaschi, Umberto Maggiore. Once-daily prolonged-release tacrolimus formulations for kidney transplantation: what the nephrologist needs to know. Journal of Nephrology 2017; 30(1): 53 doi: 10.1007/s40620-016-0316-3
|
| 52 |
Bo‐Göran Ericzon, Evaristo Varo, Pavel Trunečka, Lutz Fischer, Michele Colledan, Bruno Gridelli, Andrés Valdivieso, John O'Grady, James Dickinson, Nasrullah Undre. Pharmacokinetics of prolonged‐release tacrolimus versus immediate‐release tacrolimus in de novo liver transplantation: A randomized phase III substudy. Clinical Transplantation 2017; 31(6) doi: 10.1111/ctr.12958
|
| 53 |
D. J. A. R Moes, S. A. S van der Bent, J. J. Swen, T. van der Straaten, A. Inderson, E. Olofsen, H. W. Verspaget, H. J. Guchelaar, J. den Hartigh, B. van Hoek. Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients. European Journal of Clinical Pharmacology 2016; 72(2): 163 doi: 10.1007/s00228-015-1963-3
|
| 54 |
Megan V. Yanik, Michael E. Seifert, Jayme E. Locke, Vera Hauptfeld‐Dolejsek, Michael R. Crowley, Gary R. Cutter, Roslyn B. Mannon, Daniel I. Feig, Nita A. Limdi. CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients. Pediatric Transplantation 2019; 23(5) doi: 10.1111/petr.13494
|
| 55 |
Kristine Kloster-Jensen, Nils Tore Vethe, Sara Bremer, Shadab Abadpour, Olle Korsgren, Aksel Foss, Stein Bergan, Hanne Scholz. Intracellular sirolimus concentration is reduced by tacrolimus in human pancreatic islets in vitro. Transplant International 2015; 28(10): 1152 doi: 10.1111/tri.12617
|
| 56 |
Suwasin Udomkarnjananun, Natavudh Townamchai, Stephen J. Kerr, Adis Tasanarong, Kajohnsak Noppakun, Adisorn Lumpaopong, Surazee Prommool, Thanom Supaporn, Yingyos Avihingsanon, Kearkiat Praditpornsilpa, Somchai Eiam-ong. The First Asian Kidney Transplantation Prediction Models for Long-term Patient and Allograft Survival. Transplantation 2020; 104(5): 1048 doi: 10.1097/TP.0000000000002918
|
| 57 |
Kimberly M. Deininger, Shirley M. Tsunoda, Jan D. Hirsch, Heather Anderson, Yee Ming Lee, Colleen K. McIlvennan, Robert L. Page, Jacinda N. Tran, Christina L. Aquilante. National survey of physicians’ perspectives on pharmacogenetic testing in solid organ transplantation. Clinical Transplantation 2020; 34(10) doi: 10.1111/ctr.14037
|
| 58 |
Lekshmy Srinivas, Noble Gracious, Radhakrishnan R. Nair. Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.726784
|
| 59 |
Nemanja Rancic, Viktorija Dragojevic-Simic, Neven Vavic, Aleksandra Kovacevic, Zoran Segrt, Natasa Djordjevic. Economic Evaluation of Pharmacogenetic Tests in Patients Subjected to Renal Transplantation: A Review of Literature. Frontiers in Public Health 2016; 4 doi: 10.3389/fpubh.2016.00189
|
| 60 |
Mamatha T Shenoy, Jeyakumar Manavalan, Hariharan A, Suganthy K, Pradipta Kumar Mohanty . Tacrolimus Concentration/Dose Ratio: A Tool for Guiding Tacrolimus Dosage Post-renal Transplantation. Cureus 2024; doi: 10.7759/cureus.53421
|
| 61 |
Katalin Monostory, Katalin Tóth, Ádám Kiss, Edit Háfra, Nóra Csikány, József Paulik, Enikő Sárváry, László Kóbori. Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A‐status in liver transplant patients. British Journal of Clinical Pharmacology 2015; 80(6): 1429 doi: 10.1111/bcp.12747
|
| 62 |
Alessio Provenzani, Vincenzina Lo Re. Tacrolimus-induced akinetic mutism and persistent dysarthria following orthotopic liver transplantation. Neurological Sciences 2023; 44(8): 2983 doi: 10.1007/s10072-023-06760-6
|
| 63 |
Joshua A. Blatter, Stuart C. Sweet, Carol Conrad, Lara A. Danziger‐Isakov, Albert Faro, Samuel B. Goldfarb, Don Hayes, Ernestina Melicoff, Marc Schecter, Gregory Storch, Gary A. Visner, Nikki M. Williams, David Wang. Anellovirus loads are associated with outcomes in pediatric lung transplantation. Pediatric Transplantation 2018; 22(1) doi: 10.1111/petr.13069
|
| 64 |
Takamichi Sato, Junpei Konno, Akihiro Sekiguchi, Nao Yoneki, Kana Kawano, Tomohiro Hayashi, Yukina Ogawa, Aya Kikitsu, Takashi Aijima, Kazuhisa Hara, Shintaro Hara, Hitomi Hayashi, Kimiko Fuchigami, Naoko Igo, Yuki Takashima, Yuki Kobayashi, Masayuki Mori, Keiichiro Yamamoto, Makoto Niwa, Kan Saiga, Eiji Ichimura. Long-lasting immunosuppressive effects of tacrolimus-loaded micelle NK61060 in preclinical arthritis and colitis models. Therapeutic Delivery 2018; 9(10): 711 doi: 10.4155/tde-2018-0044
|
| 65 |
Itxarone Bilbao, Miguel Ángel Gómez Bravo, Alejandra Otero, Laura Lladó, José Luís Montero, Luisa González Dieguez, Javier Graus, José Antonio Pons Miñano. Effectiveness and safety of once‐daily tacrolimus formulations in de novo liver transplant recipients: The PRETHI study. Clinical Transplantation 2023; 37(12) doi: 10.1111/ctr.15105
|
| 66 |
Jennifer S. Guimbellot, David P. Nichols, John J. Brewington. Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis. Clinics in Chest Medicine 2022; 43(4): 617 doi: 10.1016/j.ccm.2022.06.005
|
| 67 |
Xandra García-González, Teresa Cabaleiro, María José Herrero, Howard McLeod, Luis A. López-Fernández. Clinical implementation of pharmacogenetics. Drug Metabolism and Personalized Therapy 2016; 31(1): 9 doi: 10.1515/dmpt-2015-0031
|
| 68 |
Sh. R. Galeev, S. V. Gautier. Risks and ways of preventing kidney dysfunction in drug-induced immunosuppression in solid organ recipients. Russian Journal of Transplantology and Artificial Organs 2022; 24(4): 24 doi: 10.15825/1995-1191-2022-4-24-38
|
| 69 |
Nouf Alotaibi. CYP3A5 Polymorphisms Leading to Tacrolimus Toxicity Following an Adult Renal Transplant. Saudi Journal of Kidney Diseases and Transplantation 2023; 34(3): 250 doi: 10.4103/1319-2442.393998
|
| 70 |
Miguel A. Gómez-Bravo, María Apellaniz-Ruiz, Magdalena Salcedo, Constantino Fondevila, Francisco Suarez, José Castellote, Sebastián Rufian, José A. Pons, Itxarone Bilbao, José M. Alamo, Olga Millán, Mercè Brunet, Cristina Rodríguez-Antona. Influence of donor liver CYP3A4*20 loss-of-function genotype on tacrolimus pharmacokinetics in transplanted patients. Pharmacogenetics and Genomics 2018; 28(2): 41 doi: 10.1097/FPC.0000000000000321
|